Overview
Dirofilaria infections, primarily caused by Dirofilaria immitis (heartworm) and Dirofilaria repens, pose significant health challenges in both veterinary and human medicine. These filarial nematodes can lead to a spectrum of clinical presentations ranging from asymptomatic infections to severe, life-threatening conditions. In dogs, D. immitis infection often manifests as a chronic, subclinical disease, while in humans, the manifestations can be diverse, including subcutaneous nodules, ocular involvement, and less commonly, pulmonary or systemic symptoms. The zoonotic potential of D. repens further complicates the clinical landscape, necessitating a multidisciplinary approach to diagnosis and management. Understanding the pathophysiology, epidemiology, clinical presentation, and diagnostic approaches is crucial for effective patient care.
Pathophysiology
The pathophysiology of Dirofilaria infections involves complex interactions between the parasite and the host immune system. Despite the presence of Dirofilaria immitis infection, studies indicate that systemic inflammation may not be pronounced, as evidenced by similar median haptoglobin (Hp) levels across microfilaremic seropositive (10.0 mg/dL), amicrofilaremic seropositive (9.1 mg/dL), and negative control groups (13.7 mg/dL) in dogs [PMID:41612543]. This suggests that many infected dogs may maintain a relatively stable inflammatory state, which could explain why some dogs remain asymptomatic or exhibit only mild clinical signs. However, the persistent presence of microfilariae can trigger localized inflammatory responses, particularly in organs such as the lungs, leading to clinical symptoms like the characteristic filarial cough observed in dogs [PMID:1834208]. This cough is often attributed to an allergic response to the parasite antigens, highlighting the role of immunopathology in disease manifestation.
In humans, the pathophysiology is less well-defined but likely involves similar mechanisms of immune modulation and tissue damage. The absence of pronounced systemic markers of inflammation in canine models suggests that clinical presentations in humans may also vary widely, from asymptomatic to severe, depending on the host's immune response and the specific organs affected. Understanding these immune interactions is crucial for developing targeted therapeutic strategies and monitoring disease progression.
Epidemiology
The epidemiology of Dirofilaria infections reflects a dynamic landscape with increasing reports of both canine and human cases across various regions. In the Balkan Peninsula, a significant rise in human dirofilariosis cases has been documented, with 46 new cases identified between 2015 and 2021, showcasing the evolving geographic distribution and prevalence of the disease [PMID:34673233]. This trend underscores the importance of surveillance and public health initiatives in endemic areas. Additionally, the emergence of Dirofilaria repens in regions like northern Italy, particularly in Tuscany and Sicily, highlights the adaptability of these parasites and their potential to spread beyond traditional endemic zones [PMID:10645559]. The identification of nine additional cases in these regions indicates a shift in the epidemiological profile, necessitating heightened awareness among healthcare providers.
Climate change and environmental factors are increasingly recognized as contributors to the expanding range of Dirofilaria species. Warmer temperatures and altered vector distributions facilitate the survival and transmission of these parasites, potentially exposing new populations to infection risks. Clinicians should remain vigilant, particularly in areas experiencing climatic changes, to promptly diagnose and manage these infections effectively.
Clinical Presentation
Clinical presentations of Dirofilaria infections vary widely depending on the species involved and the host's immune response. In dogs, many seropositive individuals, whether microfilaremic or amicrofilaremic, often remain asymptomatic or exhibit only mild signs, as indicated by the study where no significant clinical symptoms were noted despite serological evidence of infection [PMID:41612543]. This subclinical state is particularly relevant in geriatric populations, where subtle signs might be overlooked without routine screening. However, when clinical signs do occur, they can include a persistent, spasmodic cough (filarial cough) due to an allergic response to D. immitis antigens [PMID:1834208].
In human patients, the clinical spectrum is broader and can mimic other conditions, complicating diagnosis. Subcutaneous nodules and ocular involvement are common presentations, frequently mistaken for neoplastic lesions due to their firm, immobile nature [PMID:34673233]. Surgical interventions, such as the removal of nematode specimens, have been reported in cases where definitive diagnosis was achieved through morphological examination and PCR techniques [PMID:10645559]. These cases highlight the necessity for thorough clinical evaluation and interdisciplinary collaboration between medical professionals and veterinarians to accurately diagnose dirofilariosis, especially given its zoonotic nature.
Diagnosis
Diagnosing Dirofilaria infections requires a multifaceted approach given the diverse clinical presentations and the need for accurate differentiation from other conditions. While haptoglobin levels, as measured in canine studies, do not serve as a definitive biomarker for diagnosing D. immitis infection due to similar levels across infected and control groups [PMID:41612543], other diagnostic tools are crucial. Serological tests, including antigen and antibody detection assays, remain foundational in identifying exposure and infection status. Imaging techniques, such as ultrasound and MRI, can also play a pivotal role, particularly in detecting adult worms or associated tissue changes in organs like the lungs and eyes.
For human cases, interdisciplinary collaboration is essential, as highlighted by the necessity for coordination between medical professionals and veterinarians to ensure comprehensive diagnostic evaluation [PMID:34673233]. Molecular diagnostics, such as PCR-based techniques, have emerged as highly sensitive methods for confirming infections, especially when applied to tissue samples or surgically removed specimens [PMID:10645559]. Morphological examination of nematodes, particularly after surgical removal, provides definitive evidence and aids in distinguishing between D. immitis and D. repens based on specific morphological characteristics.
Differential Diagnosis
Differentiating Dirofilaria infections from other conditions is critical due to their varied clinical presentations that can mimic a range of diseases. Subcutaneous nodules, a common manifestation, are frequently misdiagnosed as neoplastic lesions, emphasizing the need for thorough differential diagnosis [PMID:34673233]. In ocular involvement, conditions such as uveitis or retinal detachments must be ruled out. Pulmonary symptoms, including persistent cough and respiratory distress, can overlap with chronic obstructive pulmonary disease (COPD), tuberculosis, or other parasitic infections like strongyloidiasis. Clinicians should consider a broad differential diagnosis that includes neoplastic processes, inflammatory disorders, and other parasitic infections, ensuring that appropriate diagnostic workups are conducted to exclude these possibilities.
Management
The management of Dirofilaria infections presents challenges due to the diverse clinical manifestations and potential for misdiagnosis. Treatment strategies often depend on the stage and severity of the infection. In canine patients, antigen-based immunotherapy, such as subcutaneous injections of worm antigens from D. immitis, has shown promise, with complete cures in some cases and marked improvement in others [PMID:1834208]. However, definitive treatment typically involves anthelmintic medications like melarsomine dihydrochloride for D. immitis infections, tailored to the specific life stage of the parasite.
For human cases, management is more complex and may require surgical intervention for localized infections, particularly when nodules or ocular involvement necessitates removal of the parasite [PMID:10645559]. Antiparasitic drugs such as diethylcarbamazine (DEC) or ivermectin are commonly used, though their efficacy can vary based on the species and stage of infection. Supportive care, including symptomatic treatment for respiratory distress or ocular inflammation, is also crucial. Given the potential for misdiagnosis and varied clinical presentations, heightened clinical awareness and prompt, accurate diagnosis are paramount to effective management.
Special Populations
Special attention should be given to geriatric populations and individuals residing in endemic areas, as these groups may be more susceptible to Dirofilaria infections. Older adults, both human and canine, might present with milder or atypical symptoms due to age-related changes in immune function, making subclinical infections more prevalent and harder to detect [PMID:41612543]. In endemic regions, heightened environmental exposure increases the risk of infection, necessitating regular screening and preventive measures such as vector control and prophylactic treatments. Public health initiatives should focus on educating these populations about the risks and promoting early detection through routine veterinary and medical check-ups. Understanding the unique vulnerabilities of these groups is essential for developing targeted prevention and intervention strategies.
Key Recommendations
References
1 Chocobar MLE, Eckersall DP, Panarese R, Weir W, Schmidt EMS. Comparison of Haptoglobin Concentrations Between Microfilaremic and Amicrofilaremic Dogs Infected by Dirofilaria immitis. Veterinary clinical pathology 2026. link 2 Momčilović S, Gabrielli S, Đenić N, Živković N, Stevanović G, Krstić M et al.. New cases of human dirofilariosis on the Balkan Peninsula - "Masked intruders" uncovered by a surgeon. Parasitology international 2022. link 3 Cancrini G, Favia G, Giannetto S, Merulla R, Russo R, Ubaldino V et al.. Nine more cases of human infections by Dirofilaria repens diagnosed in Italy by morphology and recombinant DNA technology. Parassitologia 1998. link 4 Hayasaki M, Harayama A, Seki H, Konno K, Ohishi I. Immunological treatment of cough occurring in dogs with dirofilariosis. The Journal of veterinary medical science 1991. link